Soft Gel Capsules

Our domain strategy of developing a comprehensive product portfolio in complex therapeutic segments such as immune-suppressants, anti-virals, high-end antibiotics has attracted marquee partnerships in Regulated markets such as US, UK, Australia and S. Africa. The partnerships we have forged with major pharma players have provided an opportunity for Strides to play an increasingly important role in the global pharma industry. As a next step Strides is enhancing its front-end operations in US and UK to be better positioned to seize new opportunities.